Talquetamab (JNJ-64407564) is a potentially first-in-class humanized IgG4/lambda bispecific antibody that binds to GPRC5D (G-protein-coupled receptor family, group C5, member D) and CD3, and induces T-cell-mediated by T-cell recruitment and activation. killing of GPRC5-expressing MM cells through T cell recruitment and activation.Talquetamab (JNJ-64407564) has antitumor activity.
Purity:
>98.0%
CAS Number:
[2226212-40-2]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
